e-learning
resources
ERJ
2017
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far
Robert P. Baughman, Oksana A. Shlobin
Source:
Eur Respir J, 50 (4) 1701725; 10.1183/13993003.01725-2017
Journal Issue:
October
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Robert P. Baughman, Oksana A. Shlobin. Treatment of sarcoidosis-associated pulmonary hypertension: so close, and yet so far. Eur Respir J, 50 (4) 1701725; 10.1183/13993003.01725-2017
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Diagnosis and treatment of pulmonary hypertension in COPD patients: how far should we go?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy?
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005
Pulmonary hypertension
Source: Eur Respir Rev 2013; 22: 20-25
Year: 2013
Treatment of pulmonary hypertension
Source: Virtual Congress 2020 – Treatment in pulmonary hypertension
Year: 2020
Update on current treatment options of pulmonary hypertension
Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine
Year: 2006
Long-term outcome of sarcoidosis-associated pulmonary hypertension in the modern treatment era
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015
Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy?
Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights
Year: 2015
Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005
Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension?
Source: Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020
Year: 2020
Riociguat for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Real-life data from the EXPERT registry
Source: International Congress 2015 – Pulmonary hypertension: new treatment insights
Year: 2015
Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
The effect of treatment on right ventriculo-arterial coupling in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013
Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics
Source: Eur Respir J 2005; 25: 783-788
Year: 2005
Observational retrospective study on the treatment of pulmonary hypertension (PH) associated to pulmonary disease in patient with PH out of proportion
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept